Overview and practical recommendations on using Shapley Values for identifying predictive biomarkers via CATE modeling
David Svensson, Erik Hermansson, Nikolaos Nikolaou, Konstantinos, Sechidis, Ilya Lipkovich

TL;DR
This paper explores how Shapley Values can be effectively used to identify predictive biomarkers through CATE modeling, addressing computational challenges and benchmarking different meta-learner strategies.
Contribution
It introduces a surrogate estimation method for SHAP in multi-stage CATE models that reduces computational load and is strategy-agnostic.
Findings
Surrogate approach improves computational efficiency
Benchmarking shows effective biomarker identification
Method applicable across various CATE meta-learners
Abstract
In recent years, two parallel research trends have emerged in machine learning, yet their intersections remain largely unexplored. On one hand, there has been a significant increase in literature focused on Individual Treatment Effect (ITE) modeling, particularly targeting the Conditional Average Treatment Effect (CATE) using meta-learner techniques. These approaches often aim to identify causal effects from observational data. On the other hand, the field of Explainable Machine Learning (XML) has gained traction, with various approaches developed to explain complex models and make their predictions more interpretable. A prominent technique in this area is Shapley Additive Explanations (SHAP), which has become mainstream in data science for analyzing supervised learning models. However, there has been limited exploration of SHAP application in identifying predictive biomarkers through…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods in Clinical Trials
MethodsShapley Additive Explanations
